- Investing Ideas
- U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
U.K. Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
1 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Diaceutics
Market Cap: UK£115.6m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
New
DXRX
UK£1.44
7D
11.2%
1Y
7.5%
AstraZeneca
Market Cap: UK£197.3b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£126.32
7D
-0.3%
1Y
13.8%
hVIVO
Market Cap: UK£53.2m
Operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America.
HVO
UK£0.074
7D
-1.3%
1Y
-26.0%